查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲目標定序市場：按應用、按產品類型、按靶向序列捕獲方法、按目標捕獲類型、按最終用戶、按國家/地區 - 分析和預測 (2024-2033)
市場調查報告書
商品編碼
1614810

歐洲目標定序市場：按應用、按產品類型、按靶向序列捕獲方法、按目標捕獲類型、按最終用戶、按國家/地區 - 分析和預測 (2024-2033)

Europe Targeted Sequencing Market: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Country - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 61 Pages | 商品交期: 1-5個工作天內

價格

2023年歐洲標靶定序市場規模達8.038億美元。

預計2024年至2033年該市場將以11.53%的複合年成長率成長，2033年達到23.733億美元。歐洲靶向定序市場競爭激烈，現有企業和新參與企業都在爭奪市場佔有率。市場的預期成長和演變帶來了挑戰和機遇，未來幾年作為一個充滿活力和快速變化的市場需要密切關注。

主要市場統計數據
預測期 2024-2033
2024年評估 8.888 億美元
2033 年預測 23.733 億美元
複合年成長率 11.53%

由於個人化治療、基因組研究以及癌症和遺傳疾病發病率上升等發展，歐洲靶向定序市場預計將顯著成長。臨床診斷、藥物開發和研究應用擴大使用標靶定序，這是一種用於詢問特定基因組區域的準確且廉價的技術。它比傳統定序技術更受青睞，因為它可以在更短的時間內以更低的成本提供高解析度資料。

由於該地區在基因組分析和生物技術開發投資的推動下對醫療保健創新的關注，該市場正在不斷成長。強大的醫療保健系統和政府對基因組研究的津貼正在加速德國、英國和法國等國家的靶向定序技術的使用。此外，該市場還受益於對嚴重依賴準確基因分析的個人化醫療和伴同性診斷不斷成長的需求。

然而，挑戰仍然存在，包括高昂的前期成本、複雜的資料解釋和監管障礙。然而，持續的創新，例如生物資訊學和人工智慧的融合，有望解決這些問題並創造新的前景。由於臨床和研究領域的接受度不斷提高，歐洲標靶定序市場預計將成為基因組學和精準醫療進步不可或缺的一部分。

該報告調查了歐洲目標定序市場，並按應用、產品類型、靶向序列捕獲、目標捕獲類型、最終用戶、國家和市場參與者提供了市場概述。

目錄

執行摘要

第1章 市場

  • 趨勢：當前和未來的影響評估
  • 標靶定序工作流程
  • 研究發展回顧
  • 監管狀況
  • 市場動態：概述
    • 市場促進因素
    • 市場限制因素
    • 市場機會

第2章 區域

  • 區域概況
  • 促進因素和抑制因素
  • 歐洲
    • 區域概況
    • 法國
    • 德國
    • 英國
    • 西班牙
    • 義大利
    • 其他

第3章市場－競爭基準化分析和

  • 公司簡介
  • 未來展望
  • 競爭格局
    • F. Hoffmann-La Roche Ltd
    • LGC Limited
    • QIAGEN NV

第4章調查方法

Product Code: BHP2404SS

Introduction to Europe Targeted Sequencing Market

The Europe targeted sequencing market was valued at $803.8 million in 2023 and is expected to reach $2,373.3 million by 2033, growing at a CAGR of 11.53% between 2024 and 2033. The Europe targeted sequencing market is highly competitive, with established companies and new entrants vying for market share. The market's anticipated growth and evolution present a mix of challenges and opportunities, positioning it as a dynamic and rapidly changing landscape to monitor in the coming years.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$888.8 Million
2033 Forecast$2,373.3 Million
CAGR11.53%

The market for targeted sequencing in Europe is expected to increase significantly due to developments in customized treatment, genomic research, and the rising incidence of cancer and genetic disorders. Clinical diagnostics, medication development, and research applications are increasingly using targeted sequencing, a precise and affordable technique for examining particular genome regions. It is favored over conventional sequencing techniques because it may produce high-resolution data in less time and at a lower cost.

The market is growing as a result of the region's strong emphasis on healthcare innovation, which is bolstered by investments in genomics and biotechnological developments. Targeted sequencing technology use is accelerating in nations like Germany, the UK, and France thanks to strong healthcare systems and government funding for genomic research. Additionally, the market gains from the growing demand for personalized medicine and companion diagnostics, which rely heavily on precise genetic analysis.

Nevertheless, issues including exorbitant upfront expenses, intricate data interpretation, and regulatory barriers continue to exist. Nevertheless, it is anticipated that ongoing innovation, such as the fusion of bioinformatics and artificial intelligence, will resolve these issues and create new prospects. The targeted sequencing market in Europe is expected to be crucial to the advancement of genomics and precision healthcare due to its growing acceptance in the clinical and research sectors.

Market Segmentation

Segmentation 1: by Application

  • Cancer
  • Reproductive Health
  • Hereditary Diseases
  • Neurological Disorders
  • Infectious Diseases
  • Cardiovascular Diseases
  • Rare Diseases
  • Other Applications

Segmentation 2: by End User

  • Diagnostic and Clinical Laboratories
  • Academic and Research Institutions
  • Pharmaceutical and Biotech Companies
  • Other End Users

Segmentation 3: by Product Type

  • Instruments
  • Services
  • Kits/Panels and Assays
  • Others

Segmentation 4: by Target Enrichment Method

  • Hybridization Capture
  • Amplicon Sequencing
  • Other Target Enrichment Methods

Segmentation 5: by Target Capture

  • Targeted DNA Sequencing
  • Targeted RNA Sequencing
  • Other Types of Target Capture

Segmentation 6: by Country

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The Europe targeted sequencing market (by application) has been segmented into detailed segments of the application of targeted sequencing based on applications, including cancer, reproductive health, hereditary diseases, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases, and other applications.

Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enable prominent players to command premium prices while maintaining growth in revenue and volume.

Competitive Strategy: Key players in the Europe targeted sequencing market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe targeted sequencing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations are expected to aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some of the prominent companies in this market are:

  • F. Hoffmann-La Roche Ltd
  • LGC Limited
  • QIAGEN N.V.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Number of Targeted Sequencing Products and Services in the Market
    • 1.1.2 Increasing Synergistic Partnerships between Market Players
  • 1.2 Targeted Sequencing Workflow
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Year)
  • 1.4 Regulatory Landscape
  • 1.5 Market Dynamics: Overview
    • 1.5.1 Market Drivers
      • 1.5.1.1 Increasing Demand for High Depth of Coverage in Sequencing
      • 1.5.1.2 Cost and Data Management Benefits of Targeted Sequencing as Compared to WGS
    • 1.5.2 Market Restraints
      • 1.5.2.1 Lack of Advanced Genomic Testing Centers
      • 1.5.2.2 Lack of Knowledge about New Genes
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Increasing Use in Clinical Research and Trials for Better Disease Pathogenesis and/or Clinical Relevance
      • 1.5.3.2 Increasing Adoption in Targeted Therapeutics in Oncology

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Regional Overview
      • 2.3.1.1 Driving Factors for Market Growth
      • 2.3.1.2 Factors Challenging the Market
    • 2.3.2 Application
    • 2.3.3 Product
    • 2.3.4 France
    • 2.3.5 Application
    • 2.3.6 Product
    • 2.3.7 Germany
    • 2.3.8 Application
    • 2.3.9 Product
    • 2.3.10 U.K.
    • 2.3.11 Application
    • 2.3.12 Product
    • 2.3.13 Spain
    • 2.3.14 Application
    • 2.3.15 Product
    • 2.3.16 Italy
    • 2.3.17 Application
    • 2.3.18 Product
    • 2.3.19 Rest-of-Europe
    • 2.3.20 Application
    • 2.3.21 Product

3 Markets - Competitive Benchmarking &

Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Competitive Landscape
    • 3.2.1 F. Hoffmann-La Roche Ltd
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Target Customers
      • 3.2.1.5 Key Personnel
      • 3.2.1.6 Analyst View
    • 3.2.2 LGC Limited
      • 3.2.2.1 Overview
      • 3.2.2.2 Top Products
      • 3.2.2.3 Top Competitors
      • 3.2.2.4 Target Customers
      • 3.2.2.5 Key Personnel
      • 3.2.2.6 Analyst View
    • 3.2.3 QIAGEN N.V.
      • 3.2.3.1 Overview
      • 3.2.3.2 Top Products
      • 3.2.3.3 Top Competitors
      • 3.2.3.4 Target Customers
      • 3.2.3.5 Key Personnel
      • 3.2.3.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Targeted Sequencing Market, $Million, 2024, 2027, and 2033
  • Figure 2: Targeted Sequencing Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 3: Europe Targeted Sequencing Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 4: Europe Targeted Sequencing Market (by Target Enrichment Method), $Million, 2023, 2027, and 2033
  • Figure 5: Europe Targeted Sequencing Market (by Target Capture), $Million, 2023, 2027, and 2033
  • Figure 6: Europe Targeted Sequencing Market (by End User), $Million, 2023, 2027, and 2033
  • Figure 7: Europe Targeted Sequencing Market (by Product Type), $Million, 2023, 2027, and 2033
  • Figure 8: Key Industrial Developments in Europe Targeted Sequencing Market, 2023
  • Figure 9: Workflow of Targeted Sequencing
  • Figure 10: Targeted Sequencing Market, Number of Patents (by Country), January 2019-February 2024
  • Figure 11: Targeted Sequencing Market (by Year), January 2019-February 2024
  • Figure 12: France Targeted Sequencing Market, $Million, 2023-2033
  • Figure 13: Germany Targeted Sequencing Market, $Million, 2023-2033
  • Figure 14: U.K. Targeted Sequencing Market, $Million, 2023-2033
  • Figure 15: Spain Targeted Sequencing Market, $Million, 2023-2033
  • Figure 16: Italy Targeted Sequencing Market, $Million, 2023-2033
  • Figure 17: Rest-of-Europe Targeted Sequencing Market, $Million, 2023-2033
  • Figure 18: Share of Strategic Initiatives
  • Figure 19: Data Triangulation
  • Figure 20: Top-Down and Bottom-Up Approach
  • Figure 21: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Europe Targeted Sequencing Market, Opportunities
  • Table 3: Europe Targeted Sequencing Market, Trend Analysis
  • Table 4: Some Product Launches in the Targeted Sequencing Market
  • Table 5: Targeted Sequencing Market, Key Partnerships and Collaborations
  • Table 6: Targeted Sequencing Market, Regulatory Landscape
  • Table 7: Impact Analysis of Market Navigating Factors, 2023-2033
  • Table 8: Comparison Between Types of Next-Generation Sequencing Techniques
  • Table 9: Targeted Sequencing Market (by Region), $Million, 2023-2033
  • Table 10: Europe Targeted Sequencing Market (by Application), $Million, 2023-2033
  • Table 11: Europe Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 12: Europe Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 13: Europe Targeted Sequencing Market (by Target Enrichment Methods), $Million, 2023-2033
  • Table 14: Europe Targeted Sequencing Market (by Type of Target Capture), $Million, 2023-2033
  • Table 15: France Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 16: France Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 17: Germany Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 18: Germany Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 19: U.K. Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 20: U.K. Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 21: Spain Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 22: Spain Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 23: Italy Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 24: Italy Targeted Sequencing Market (by Product Type), $Million, 2023-2033
  • Table 25: Rest-of-Europe Targeted Sequencing Market (by End User), $Million, 2023-2033
  • Table 26: Rest-of-Europe Targeted Sequencing Market (by Product Type), $Million, 2023-2033